You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
The effect of rituximab therapy on immunoglobulin levels in patients with multisystem autoimmune disease
|
---|---|
Published in |
BMC Musculoskeletal Disorders, May 2014
|
DOI | 10.1186/1471-2474-15-178 |
Pubmed ID | |
Authors |
Helena Marco, Rona M Smith, Rachel B Jones, Mary-Jane Guerry, Fausta Catapano, Stella Burns, Afzal N Chaudhry, Kenneth GC Smith, David RW Jayne |
Abstract |
Rituximab is a B cell depleting anti-CD20 monoclonal antibody. CD20 is not expressed on mature plasma cells and accordingly rituximab does not have immediate effects on immunoglobulin levels. However, after rituximab some patients develop hypogammaglobulinaemia. |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Germany | 1 | 33% |
Unknown | 2 | 67% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 67% |
Practitioners (doctors, other healthcare professionals) | 1 | 33% |
Mendeley readers
The data shown below were compiled from readership statistics for 96 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Russia | 1 | 1% |
Unknown | 95 | 99% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 12 | 13% |
Other | 11 | 11% |
Researcher | 9 | 9% |
Student > Postgraduate | 8 | 8% |
Student > Doctoral Student | 8 | 8% |
Other | 28 | 29% |
Unknown | 20 | 21% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 51 | 53% |
Biochemistry, Genetics and Molecular Biology | 6 | 6% |
Agricultural and Biological Sciences | 5 | 5% |
Immunology and Microbiology | 3 | 3% |
Engineering | 2 | 2% |
Other | 5 | 5% |
Unknown | 24 | 25% |
Attention Score in Context
This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 May 2014.
All research outputs
#2,870,166
of 22,756,196 outputs
Outputs from BMC Musculoskeletal Disorders
#586
of 4,037 outputs
Outputs of similar age
#30,006
of 226,180 outputs
Outputs of similar age from BMC Musculoskeletal Disorders
#9
of 99 outputs
Altmetric has tracked 22,756,196 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,037 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.0. This one has done well, scoring higher than 85% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 226,180 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 86% of its contemporaries.
We're also able to compare this research output to 99 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 90% of its contemporaries.